Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Oncogene Année : 2009

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Jérôme Moreaux
John de Vos

Résumé

Pathogenesis of multiple myeloma is associated with an aberrant expression of pro-proliferative, pro-angiogenic and bone-metabolism-modifying factors by malignant plasma cells. Given the frequently long time span from diagnosis of early-stage plasma cell dyscrasias to overt myeloma and the mostly low proliferation rate of malignant plasma cells, we hypothesize these to similarly express a novel class of inhibitory factors of potential prognostic relevance. Bone morphogenic proteins (BMPs) represent possible candidates as they inhibit proliferation, stimulate bone formation and have an effect on the survival of cancer patients. We assessed the expression of BMPs and their receptors by Affymetrix DNA microarrays (n=779) including CD138-purified primary myeloma cell samples (n=635) of previously untreated patients. BMP6 is the only BMP expressed by malignant and normal plasma cells. Its expression is significantly lower in proliferating myeloma cells, myeloma cell lines or plasmablasts. BMP6 significantly inhibits the proliferation of myeloma cell lines, survival of primary myeloma cells and in vitro angiogenesis. A high BMP6 expression in primary myeloma cell samples delineates significantly superior overall survival for patients undergoing high-dose chemotherapy independent of conventional prognostic factors (International Staging System (ISS) stage, beta(2) microglobulin).
Fichier principal
Vignette du fichier
BMP6_in_Myeloma_Suppl_Material_Oncogene_Resubmission.pdf (70.44 Ko) Télécharger le fichier
BMP6_in_Myeloma_Figures_Oncogene_Resubmission.pdf (731.06 Ko) Télécharger le fichier
BMP6_in_Myeloma_Figures_Oncogene_Resubmission.ppt (1.47 Mo) Télécharger le fichier
BMP6_in_Myeloma_Manuscript_Oncogene_Resubmission.pdf (123.13 Ko) Télécharger le fichier
inserm-00437705_edited.pdf (706.09 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Format : Autre
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-00437705 , version 1 (26-02-2010)

Identifiants

Citer

Anja Seckinger, Tobias Meissner, Jérôme Moreaux, Hartmut Goldschmidt, Gwenny M. Fuhler, et al.. Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.. Oncogene, 2009, 28 (44), pp.3866-79. ⟨10.1038/onc.2009.257⟩. ⟨inserm-00437705⟩
302 Consultations
1760 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More